Profile picture

Doctor Leslie Cho

Cleveland Clinic, Cleveland (United States of America)
Membership: FESC Member
Follow
Biography
Leslie Cho, MD, is Director of the Cleveland Clinic’s Women’s Cardiovascular Center. She is also Section Head, Preventive Cardiology and Rehabilitation and the Chief Quality Officer in the Robert and Suzanne Tomsich Department of Cardiovascular Medicine at Cleveland Clinic. She is a professor of Medicine at Cleveland Clinic Lerner School of Medicine Case Western Reserve Medical School. Dr. Cho is board-certified in interventional cardiology, cardiovascular medicine, and internal medicine. Dr. Cho’s clinical research interests are women and heart disease and the role of new treatments for hyperlipidemia and novel risk factor. She serves on multiple steering committees for international randomized controlled trials in cardiology. She is a special consultant to the FDA and is the chair elect for ACC CVD in Women group.
Logo ESC

Contributor content

Lipids (2)
Session
Lipids (2)
31 August 2025
Risk factors: biomarkers
Session
Risk factors: biomarkers
31 August 2025
Changing face of lipid-lowering therapy
Session
Changing face of lipid-lowering therapy
29 August 2025
Navigating complex decision making: personalised care beyond the guidelines
Session
Navigating complex decision making: personalised care beyond the guidelines
29 August 2025
Navigating complex decision making: personalised care beyond the guidelines
Session
Navigating complex decision making: personalised care beyond the guidelines
30 August 2024
Meet the Trialist - ALL-HEART
Session
Meet the Trialist - ALL-HEART
27 August 2022
New insights into sex differences in acute coronary syndromes
Session
New insights into sex differences in acute coronary syndromes
1 September 2019
Diet and risk reduction of cardiovascular disease - Evidence, controversies, and consensus
Session
Diet and risk reduction of cardiovascular disease - Evidence, controversies, and consensus
1 September 2019
Cardiovascular risk reduction and the role of lipoprotein(a): present and future therapeutic options
Session
Cardiovascular risk reduction and the role of lipoprotein(a): present and future therapeutic options
26 August 2018
Women's vessels: another mystery
Session
Women's vessels: another mystery
29 August 2017

ESC 365 is supported by